Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...

The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...

Catalent CTLT recently announced that it has entered into a definitive agreement to sell its oral solids development and ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, ...

Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in ...

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to contract manufacturer Ardena. Financial details of the agreement ...

Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer ...

The Somerset facility also houses Catalent’s corporate headquarters, which in the near term will remain at the Somerset site during a transition period before shifting to a new location.

(RTTNews) - Catalent, Inc. (CTLT), a provider of advanced ... solids development and small-scale manufacturing facility in Somerset, NJ to Ardena, a Contract Development and Manufacturing ...

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered ...